The Republic of Korea has emerged as a global leader in research and development, manufacturing, and innovation, with growing potential to help transform how health challenges are addressed worldwide. This panel will explore how Korean companies, health technologies, and public sector partners can accelerate access to AI-enabled tools, diagnostics, and other health solutions, with tuberculosis serving as an entry point in high-burden, high-growth countries. Panelists will discuss what is needed to move promising innovations from development to large-scale adoption. The conversation will also highlight opportunities for cross-sector partnerships that can strengthen health systems and advance more equitable health outcomes. The Stop TB Partnership is a programming partner for the 2026 Annual Summit.
Energy, Environment, & Transition
Studio Stage: A Pro-Market Path to Decarbonization
Efforts to decarbonize the global economy have increasingly run into political and practical challenges, with top-down approaches often proving fragmented, slow, or contested. In this Studio Stage talk, Professor Karthik Ramanna explores a pro-market approach to decarbonization, highlighting how rigorous…
